Literature DB >> 21128015

Latent tuberculosis in children: diagnosis and management.

Meenu Singh1, Arushi Gahlot Saini, Nidhi Anil, Amit Aggarwal.   

Abstract

Control of tuberculosis in children often escapes attention because of the paucibacillary nature of the illness. However, they contribute much of the morbidity, mortality and future reservoir of the disease which reiterates the importance of risk-factor based screening for latent infection and appropriate treatment. We review the modalities and importance of diagnosis and treatment of latent tuberculosis infection in children. At this time, the role for interferon-gamma release assays in low-income, high-burden settings is rather limited but further research in the coming years might clear their role in children. An important emerging area of research is the development of an improved skin test for TB that uses specific mycobacterial antigens rather than tuberculin, thus is more feasible and useful in resource limited settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21128015     DOI: 10.1007/s12098-010-0295-7

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  43 in total

1.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak.

Authors:  Katie Ewer; Jonathan Deeks; Lydia Alvarez; Gerry Bryant; Sue Waller; Peter Andersen; Philip Monk; Ajit Lalvani
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

Review 2.  Use of the tuberculin skin test in children.

Authors:  Donald A Enarson
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

Review 3.  Controlled chemoprophylaxis trials in tuberculosis. A general review.

Authors:  S H Ferebee
Journal:  Bibl Tuberc       Date:  1970

4.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

5.  Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Authors:  A K Detjen; T Keil; S Roll; B Hauer; H Mauch; U Wahn; K Magdorf
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

6.  Paediatric tuberculosis and DOTS strategy under RNTCP.

Authors:  Satish Chugh
Journal:  J Indian Med Assoc       Date:  2008-12

7.  Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact.

Authors:  Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Jonathan J Deeks; Serpil Efee; Yasemin Aslan; Davinder P S Dosanjh; Ajit Lalvani
Journal:  Ann Intern Med       Date:  2008-10-20       Impact factor: 25.391

8.  Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis.

Authors:  Roland Diel; Robert Loddenkemper; Karen Meywald-Walter; Rene Gottschalk; Albert Nienhaus
Journal:  Chest       Date:  2008-11-18       Impact factor: 9.410

Review 9.  Latent tuberculosis: which test in which situation?

Authors:  Jean-Pierre Zellweger
Journal:  Swiss Med Wkly       Date:  2008-01-26       Impact factor: 2.193

10.  Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting.

Authors:  Mark P Nicol; Mary-Ann Davies; Kathryn Wood; Mark Hatherill; Lesley Workman; Anthony Hawkridge; Brian Eley; Katalin A Wilkinson; Robert J Wilkinson; Willem A Hanekom; David Beatty; Gregory Hussey
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  1 in total

1.  Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10.

Authors:  Roxana Mansour Ghanaie; Abdollah Karimi; Leila Azimi; Seddon James; Mahshid Nasehi; Abolfazl Panahi Mishkar; Mahnaz Sheikhi; Fatemeh Fallah; Sedigheh Rafiei Tabatabaei; Seyedeh Mahsan Hoseini-Alfatemi
Journal:  BMC Pediatr       Date:  2021-02-11       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.